Literature DB >> 28943214

Down-regulation of miR-605 promotes the proliferation and invasion of prostate cancer cells by up-regulating EN2.

Yao-Jun Zhou1, Hong-Qiong Yang2, Wei Xia1, Li Cui1, Ren-Fang Xu1, Hao Lu1, Zhong Xue1, Bo Zhang1, Zi-Nong Tian1, Yun-Jie Cao1, Zhao-Yu Xing1, Shuai Yin1, Xiao-Zhou He3.   

Abstract

AIMS: MicroRNA served as inhibitor for gene expression in various cancers. This study aimed to investigate the role of miR-605 and EN2 in prostate cancer (PCa).
MATERIALS AND METHODS: In this research, the expression of miR-605 and EN2 protein in PCa tissues and cells were determined by qRT-PCR and western blot, respectively. The cell proliferation was measured by Cell Counting Kit-8 (CCK-8) and the tumor cell invasion assay was accomplished with transwell system. Flow cytometry was used to analyze the cell cycle. The endogenous expression of miR-605 and EN2 was modulated by recombinant plasmids and cell transfection. Dual luciferase reporter assay was performed to determine the interaction between miR-605 and EN2 in PCa cells. KEY
FINDINGS: The expression of miR-605 was lower in PCa tissue and cells than that in normal tissues and cells, while the expression of EN2 was just the opposite. Down-regulation of the EN2 by siRNA inhibited the proliferation and invasion of PC3 cells, and the cell cycle was arrested in G0/G1 phase. EN2 regulated the expression of E-cadherin and Vimentin through Snail and EN2 regulated the cell cycle and cell proliferation via PI3K/AKT pathway. MiR-605 inhibited the proliferation and invasion of PCa cells through targeting EN2. SIGNIFICANCE: EN2 is negatively regulated by miR-605, and down-regulation of miR-605 promotes the proliferation and invasion of PCa cells by up-regulating EN2, which leads to PCa development and progression.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  EN2; PCa; PCa cells; miR-605

Mesh:

Substances:

Year:  2017        PMID: 28943214     DOI: 10.1016/j.lfs.2017.09.028

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  11 in total

1.  MicroRNA-like snoRNA-Derived RNAs (sdRNAs) Promote Castration-Resistant Prostate Cancer.

Authors:  Alexander B Coley; Ashlyn N Stahly; Mohan V Kasukurthi; Addison A Barchie; Sam B Hutcheson; Dominika Houserova; Yulong Huang; Brianna C Watters; Valeria M King; Meghan A Dean; Justin T Roberts; Jeffrey D DeMeis; Krisha V Amin; Cameron H McInnis; Noel L Godang; Ryan M Wright; David F Haider; Neha B Piracha; Cana L Brown; Zohaib M Ijaz; Shengyu Li; Yaguang Xi; Oliver G McDonald; Jingshan Huang; Glen M Borchert
Journal:  Cells       Date:  2022-04-12       Impact factor: 7.666

2.  Phase I study of the mTOR inhibitor everolimus in combination with the histone deacetylase inhibitor panobinostat in patients with advanced clear cell renal cell carcinoma.

Authors:  Anthony Wood; Saby George; Nabil Adra; Sreenivasulu Chintala; Nur Damayanti; Roberto Pili
Journal:  Invest New Drugs       Date:  2019-10-25       Impact factor: 3.850

3.  microRNA-605 inhibits the oncogenicity of non-small-cell lung cancer by directly targeting Forkhead Box P1.

Authors:  Wei Zhou; Ruichao Li
Journal:  Onco Targets Ther       Date:  2019-05-17       Impact factor: 4.147

4.  microRNA-605 directly targets SOX9 to alleviate the aggressive phenotypes of glioblastoma multiforme cell lines by deactivating the PI3K/Akt pathway.

Authors:  Jianwu Jia; Jing Wang; Meifeng Yin; Yongdong Liu
Journal:  Onco Targets Ther       Date:  2019-07-08       Impact factor: 4.147

5.  UNC13C Suppress Tumor Progression via Inhibiting EMT Pathway and Improves Survival in Oral Squamous Cell Carcinoma.

Authors:  Bharath Kumar Velmurugan; Kun-Tu Yeh; Ming-Ju Hsieh; Chung-Min Yeh; Chia-Chieh Lin; Chuan-Yu Kao; Lan-Ru Huang; Shu-Hui Lin
Journal:  Front Oncol       Date:  2019-08-08       Impact factor: 6.244

6.  MicroRNA‑106b functions as an oncogene and regulates tumor viability and metastasis by targeting LARP4B in prostate cancer.

Authors:  Weiqi Yin; Junfeng Chen; Guoyao Wang; Dongxu Zhang
Journal:  Mol Med Rep       Date:  2019-06-05       Impact factor: 2.952

7.  MiR-33a targets FOSL1 and EN2 as a clinical prognostic marker for sarcopenia by glioma.

Authors:  Wei Wang; Wei Liu; Jing Xu; Hongze Jin
Journal:  Front Genet       Date:  2022-08-17       Impact factor: 4.772

8.  miR-205-5p inhibits cell migration and invasion in prostatic carcinoma by targeting ZEB1.

Authors:  Lianpeng Li; Shouqiang Li
Journal:  Oncol Lett       Date:  2018-05-31       Impact factor: 2.967

Review 9.  Epigenetic Drugs for Cancer and microRNAs: A Focus on Histone Deacetylase Inhibitors.

Authors:  Pierre Autin; Christophe Blanquart; Delphine Fradin
Journal:  Cancers (Basel)       Date:  2019-10-10       Impact factor: 6.639

10.  Circular RNA circ_0000467 regulates colorectal cancer development via miR-382-5p/EN2 axis.

Authors:  Lu Xie; Zhihong Pan
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.